These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 25213272

  • 1. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
    Moreau-Marquis S, Coutermarsh B, Stanton BA.
    J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q, Griffin EF, Moreau-Marquis S, Schwartzman JD, Stanton BA, O'Toole GA.
    J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
    [Abstract] [Full Text] [Related]

  • 3. Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum.
    Tunney MM, Payne JE, McGrath SJ, Einarsson GG, Ingram RJ, Gilpin DF, Juarez-Perez V, Elborn JS.
    J Antimicrob Chemother; 2018 Dec 01; 73(12):3391-3397. PubMed ID: 30219825
    [Abstract] [Full Text] [Related]

  • 4. Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.
    Anderson GG, Kenney TF, Macleod DL, Henig NR, O'Toole GA.
    Pathog Dis; 2013 Feb 01; 67(1):39-45. PubMed ID: 23620118
    [Abstract] [Full Text] [Related]

  • 5. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
    Anderson GG, Moreau-Marquis S, Stanton BA, O'Toole GA.
    Infect Immun; 2008 Apr 01; 76(4):1423-33. PubMed ID: 18212077
    [Abstract] [Full Text] [Related]

  • 6. The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.
    Maiden MM, Zachos MP, Waters CM.
    J Antimicrob Chemother; 2019 Apr 01; 74(4):894-906. PubMed ID: 30624737
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
    Breen SKJ, Harper M, López-Causapé C, Rogers KE, Tait JR, Smallman TR, Lang Y, Lee WL, Zhou J, Zhang Y, Bulitta JB, Nation RL, Oliver A, Boyce JD, Landersdorfer CB.
    Int J Antimicrob Agents; 2024 Jun 01; 63(6):107161. PubMed ID: 38561094
    [Abstract] [Full Text] [Related]

  • 8. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.
    Moreau-Marquis S, O'Toole GA, Stanton BA.
    Am J Respir Cell Mol Biol; 2009 Sep 01; 41(3):305-13. PubMed ID: 19168700
    [Abstract] [Full Text] [Related]

  • 9. Dispersal of Epithelium-Associated Pseudomonas aeruginosa Biofilms.
    Zemke AC, D'Amico EJ, Snell EC, Torres AM, Kasturiarachi N, Bomberger JM.
    mSphere; 2020 Jul 15; 5(4):. PubMed ID: 32669459
    [Abstract] [Full Text] [Related]

  • 10. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
    Rojo-Molinero E, Macià MD, Rubio R, Moyà B, Cabot G, López-Causapé C, Pérez JL, Cantón R, Oliver A.
    Antimicrob Agents Chemother; 2016 May 15; 60(5):2912-22. PubMed ID: 26926631
    [Abstract] [Full Text] [Related]

  • 11. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.
    Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O'Toole GA, Stanton BA.
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul 15; 295(1):L25-37. PubMed ID: 18359885
    [Abstract] [Full Text] [Related]

  • 12. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR, White A, Elborn JS, Tunney MM.
    Eur J Clin Microbiol Infect Dis; 2005 Oct 15; 24(10):677-87. PubMed ID: 16249934
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Oct 15; 34(4):370-4. PubMed ID: 19505804
    [Abstract] [Full Text] [Related]

  • 14. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE, Naimie AA, Griffin EF, Bay C, O'Toole GA.
    J Bacteriol; 2016 Jan 15; 198(2):237-47. PubMed ID: 26483523
    [Abstract] [Full Text] [Related]

  • 15. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
    Thellin O, Zorzi W, Jolois O, Elmoualij B, Duysens G, Cahay B, Streel B, Charif M, Bastin R, Heinen E, Quatresooz P.
    Int J Antimicrob Agents; 2015 Jul 15; 46(1):33-8. PubMed ID: 25963337
    [Abstract] [Full Text] [Related]

  • 16. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M, Gutu AD, Hebert W, Wager JD, Yonker LM, O'Toole GA, Ausubel FM, Moskowitz SM, Joseph-McCarthy D.
    Antimicrob Agents Chemother; 2017 Dec 15; 61(12):. PubMed ID: 28923873
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
    Tré-Hardy M, Nagant C, El Manssouri N, Vanderbist F, Traore H, Vaneechoutte M, Dehaye JP.
    Antimicrob Agents Chemother; 2010 Oct 15; 54(10):4409-15. PubMed ID: 20696878
    [Abstract] [Full Text] [Related]

  • 18. Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms.
    Eisha S, Morris AJ, Martin I, Yau YCW, Grasemann H, Waters V.
    Antimicrob Agents Chemother; 2024 Aug 07; 68(8):e0033624. PubMed ID: 39023260
    [Abstract] [Full Text] [Related]

  • 19. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms.
    Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2014 Oct 07; 58(10):5818-30. PubMed ID: 25049240
    [Abstract] [Full Text] [Related]

  • 20. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP, Melvin JA, Deslouches B, Pilewski JM, Montelaro RC, Bomberger JM.
    J Antimicrob Chemother; 2016 Aug 07; 71(8):2200-7. PubMed ID: 27231279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.